The roles of stress and social support in prostate cancer mortality

References

• Center MM, Jemal A, Lortet-Tieulent J, Ward E, Ferlay J, Brawley O, et al. International variation in prostate cancer incidence and mortality rates. Eur Urol 2012;61:1079–92.
   PubMed Web of Science ®Google Scholar
• Braun DP, Gupta D, Staren ED. Predicting survival in prostate cancer: the role of quality of life assessment. Support Care Cancer 2012;20:1267–74.
   PubMed Web of Science ®Google Scholar
• Lis CG, Gupta D, Grutsch JF. Patient satisfaction with health-related quality of life: implications for prognosis in prostate cancer. Clin Genitourin Cancer 2008;6:91–6.
   PubMed Web of Science ®Google Scholar
• Halabi S, Vogelzang NJ, Kornblith AB, Ou SS, Kantoff PW, Dawson NA, et al. Pain predicts overall survival in men with metastatic castration-refractory prostate cancer. J Clin Oncol 2008;26:2544–9.
   PubMed Web of Science ®Google Scholar
• Turner EL, Lane JA, Metcalfe C, Down L, Donovan JL, Hamdy F, et al. Psychological distress and prostate specific antigen levels in men with and without prostate cancer. Brain Behav Immun 2009;23:1073–8.
   PubMed Web of Science ®Google Scholar
• Metcalfe C, Davey Smith G, Macleod J, Hart C. The role of self-reported stress in the development of breast cancer and prostate cancer: a prospective cohort study of employed males and females with 30 years of follow-up. Eur J Cancer 2007;43:1060–5.
   PubMed Web of Science ®Google Scholar
• Nielsen NR, Kristensen TS, Zhang ZF, Strandberg-Larsen K, Schnohr P, Gronbaek M. Sociodemographic status, stress, and risk of prostate cancer. A prospective cohort study. Ann Epidemiol 2007;17:498–502.
   PubMed Web of Science ®Google Scholar
• Stone AA, Mezzacappa ES, Donatone BA, Gonder M. Psychosocial stress and social support are associated with prostate-specific antigen levels in men: results from a community screening program. Health Psychol 1999;18:482–6.
   PubMed Web of Science ®Google Scholar
• Lis CG, Gupta D, Grutsch JF. The relationship between insomnia and patient satisfaction with quality of life in cancer. Support Care Cancer 2008;16:261–6.
   PubMed Web of Science ®Google Scholar
• Gidron Y, Fabre B, Grosman H, Nolazco C, Mesch V, Mazza O, et al. Life events, cortisol and levels of prostate specific antigen: a story of synergism. Psychoneuroendocrinology 2011;36:874–80.
   PubMed Web of Science ®Google Scholar
• Schapira MM, Lawrence WF, Katz DA, McAuliffe TL, Nattinger AB. Effect of treatment on quality of life among men with clinically localized prostate cancer. Med Care 2001;39:243–53.
   PubMed Web of Science ®Google Scholar
• Cohen L, Fouladi RT, Babaian RJ, Bhadkamkar VA, Parker PA, Taylor CC, et al. Cancer worry is associated with abnormal prostate-specific antigen levels in men participating in a community screening program. Cancer Epidemiol Biomarkers Prev 2003;12:610–17.
   PubMedGoogle Scholar
• Zhou ES, Penedo FJ, Lewis JE, Rasheed M, Traeger L, Lechner S, et al. Perceived stress mediates the effects of social support on health-related quality of life among men treated for localized prostate cancer. J Psychosom Res 2010;69:587–90.
   PubMed Web of Science ®Google Scholar
• D’Amico AV, Moul JW, Carroll PR, Sun L, Lubeck D, Chen MH. Surrogate end point for prostate cancer-specific mortality after radical prostatectomy or radiation therapy. J Natl Cancer Inst 2003;95:1376–83.
   PubMed Web of Science ®Google Scholar
• Band PR, Le ND, Fang R, Deschamps M, Coldman AJ, Gallagher RP, et al. Cohort study of Air Canada pilots: mortality, cancer incidence, and leukemia risk. Am J Epidemiol 1996;143:137–43.
   PubMed Web of Science ®Google Scholar
• Nicholas JS, Lackland DT, Dosemeci M, Mohr LCJr, Dunbar JB, Grosche B, et al. Mortality among US commercial pilots and navigators. J Occup Environ Med 1998;40:980–5.
   PubMed Web of Science ®Google Scholar
• Collette L, van Andel G, Bottomley A, Oosterhof GO, Albrecht W, de Reijke TM, et al. Is baseline quality of life useful for predicting survival with hormone-refractory prostate cancer? A pooled analysis of three studies of the European Organisation for Research and Treatment of Cancer Genitourinary Group. J Clin Oncol 2004;22:3877–85.
   PubMed Web of Science ®Google Scholar
• Sullivan PW, Nelson JB, Mulani PM, Sleep D. Quality of life as a potential predictor for morbidity and mortality in patients with metastatic hormone-refractory prostate cancer. Qual Life Res 2006;15:1297–306.
   PubMed Web of Science ®Google Scholar
• Van Hemelrijck M, Wigertz A, Sandin F, Garmo H, Hellstrom K, Fransson P, et al. Cohort Profile: The National Prostate Cancer Register of Sweden and Prostate Cancer Data Base Sweden 2.0. Int J Epidemiol 2013;42:956–67.
   PubMed Web of Science ®Google Scholar
• Stattin P, Sandin F, Garmo H, Bratt O, Thellenberg C, Adolfsson J, et al. Prostate cancer: national quality report for the year of diagnosis 2011 from the National Prostate Cancer Register (NPCR). 2012. Available from http://www.cancercentrum.se/Global/RCCUppsalaOrebro/V%C3%A5rdprocesser/urologi/prostatacancer/rapporter/20121211_NPCR_ENG_Rapport_2011.pdf. Accessed 29 January 2015.
   Google Scholar
• Stattin P, Holmberg E, Bratt O, Adolfsson J, Johansson JE, Hugosson J, et al. Surveillance and deferred treatment for localized prostate cancer. Population based study in the National Prostate Cancer Register of Sweden. J Urol 2008;180:2423–9; discussion 2429–30.
   PubMed Web of Science ®Google Scholar
• Barlow L, Westergren K, Holmberg L, Talback M. The completeness of the Swedish Cancer Register: a sample survey for year 1998. Acta Oncol 2009;48:27–33.
   PubMed Web of Science ®Google Scholar
• Adolfsson J, Garmo H, Varenhorst E, Ahlgren G, Ahlstrand C, Andren O, et al. Clinical characteristics and primary treatment of prostate cancer in Sweden between 1996 and 2005. Scand J Urol Nephrol 2007;41:456–77.
   PubMed Web of Science ®Google Scholar
• Bonn SE, Sjolander A, Lagerros YT, Wiklund F, Stattin P, Holmberg E, et al. Physical activity and survival among men diagnosed with prostate cancer. Cancer Epidemiol Biomarkers Prev 2015;24:57–64.
   PubMed Web of Science ®Google Scholar
• Bonn SE, Wiklund F, Sjolander A, Szulkin R, Stattin P, Holmberg E, et al. Body mass index and weight change in men with prostate cancer: progression and mortality. Cancer Causes Control 2014;25:933–43.
   PubMed Web of Science ®Google Scholar
• Szulkin R, Holmberg E, Stattin P, Xu J, Zheng S, Palmgren J, et al. Prostate cancer risk variants are not associated with disease progression. Prostate 2012;72:30–9.
   PubMed Web of Science ®Google Scholar
• Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav 1983;24:385–96.
   PubMed Web of Science ®Google Scholar
• Norman A, Bellocco R, Bergstrom A, Wolk A. Validity and reproducibility of self-reported total physical activity – differences by relative weight. Int J Obes Relat Metab Disord 2001;25:682–8.
   PubMed Web of Science ®Google Scholar
• Lindmark F, Zheng SL, Wiklund F, Bensen J, Balter KA, Chang B, et al. H6D polymorphism in macrophage-inhibitory cytokine-1 gene associated with prostate cancer. J Natl Cancer Inst 2004;96:1248–54.
   PubMed Web of Science ®Google Scholar
• Chang ET, Hedelin M, Adami HO, Gronberg H, Balter KA. Alcohol drinking and risk of localized versus advanced and sporadic versus familial prostate cancer in Sweden. Cancer Causes Control 2005;16:275–84.
   PubMed Web of Science ®Google Scholar
• Cohen S, Janicki-Deverts D. Who’s stressed? Distributions of psychological stress in the United States in probability samples from 1983, 2006, and 2009. J Appl Soc Psychol 2012;42:1320–34.
   Web of Science ®Google Scholar
• Fondell E, Lagerros YT, Sundberg CJ, Lekander M, Balter O, Rothman KJ, et al. Physical activity, stress, and self-reported upper respiratory tract infection. Med Sci Sports Exerc 2011;43:272–9.
   PubMed Web of Science ®Google Scholar
• Sigurdardottir LG, Valdimarsdottir UA, Fall K, Rider JR, Lockley SW, Schernhammer E, et al. Circadian disruption, sleep loss, and prostate cancer risk: a systematic review of epidemiologic studies. Cancer Epidemiol Biomarkers Prev 2012;21:1002–11.
   PubMed Web of Science ®Google Scholar
• Coker AL, Sanderson M, Ellison GL, Fadden MK. Stress, coping, social support, and prostate cancer risk among older African American and Caucasian men. Ethn Dis 2006;16:978–87.
   PubMed Web of Science ®Google Scholar
• Almqvist C, Adami HO, Franks PW, Groop L, Ingelsson E, Kere J, et al. LifeGene – a large prospective population-based study of global relevance. Eur J Epidemiol 2011;26:67–77.
   PubMed Web of Science ®Google Scholar
• Fall K, Stromberg F, Rosell J, Andren O, Varenhorst E; South-East Region Prostate Cancer Group. Reliability of death certificates in prostate cancer patients. Scand J Urol Nephrol 2008;42:352–7.
   PubMed Web of Science ®Google Scholar
• Riihimaki M, Thomsen H, Brandt A, Sundquist J, Hemminki K. What do prostate cancer patients die of? Oncologist 2011;16:175–81.
   PubMed Web of Science ®Google Scholar
• Chida Y, Steptoe A. Positive psychological well-being and mortality: a quantitative review of prospective observational studies. Psychosom Med 2008;70:741–56.
   PubMed Web of Science ®Google Scholar
• Chun FK, Graefen M, Zacharias M, Haese A, Steuber T, Schlomm T, et al. Anatomic radical retropubic prostatectomy – long-term recurrence-free survival rates for localized prostate cancer. World J Urol 2006;24:273–80.
   PubMed Web of Science ®Google Scholar
• Paterson C, Jones M, Rattray J, Lauder W. Exploring the relationship between coping, social support and health-related quality of life for prostate cancer survivors: a review of the literature. Eur J Oncol Nurs 2013;17:750–9.
   PubMed Web of Science ®Google Scholar
• Braeckman J, Michielsen D. Prognostic factors in prostate cancer. Recent Results Cancer Res 2007;175:25–32.
   PubMedGoogle Scholar
• McEwen BS, Tucker P. Critical biological pathways for chronic psychosocial stress and research opportunities to advance the consideration of stress in chemical risk assessment. Am J Public Health 2011;101:S131–9.
   PubMed Web of Science ®Google Scholar
• Grytli HH, Fagerland MW, Fossa SD, Tasken KA. Association between use of beta-blockers and prostate cancer-specific survival: a cohort study of 3561 prostate cancer patients with high-risk or metastatic disease. Eur Urol 2014;65:635–41.
   PubMed Web of Science ®Google Scholar
• Zhao XY, Malloy PJ, Krishnan AV, Swami S, Navone NM, Peehl DM, et al. Glucocorticoids can promote androgen-independent growth of prostate cancer cells through a mutated androgen receptor. Nat Med 2000;6:703–6.
   PubMed Web of Science ®Google Scholar
• Hassan S, Karpova Y, Baiz D, Yancey D, Pullikuth A, Flores A, et al. Behavioral stress accelerates prostate cancer development in mice. J Clin Invest 2013;123:874–86.
   PubMed Web of Science ®Google Scholar
• Sigurdardottir LG, Valdimarsdottir UA, Mucci LA, Fall K, Rider JR, Schernhammer E, et al. Sleep disruption among older men and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 2013;22:872–9.
   PubMed Web of Science ®Google Scholar
• Bellardita L, Rancati T, Alvisi MF, Villani D, Magnani T, Marenghi C, et al. Predictors of health-related quality of life and adjustment to prostate cancer during active surveillance. Eur Urol 2013;64:30–6.
   PubMed Web of Science ®Google Scholar
• Boesen EH, Johansen C. Impact of psychotherapy on cancer survival: time to move on? Curr Opin Oncol 2008;20:372–7.
   PubMed Web of Science ®Google Scholar
• Coyne JC, Lepore SJ, Palmer SC. Efficacy of psychosocial interventions in cancer care: evidence is weaker than it first looks. Ann Behav Med 2006;32:104–10.
   PubMed Web of Science ®Google Scholar
• Kissane DW, Grabsch B, Clarke DM, Smith GC, Love AW, Bloch S, et al. Supportive-expressive group therapy for women with metastatic breast cancer: survival and psychosocial outcome from a randomized controlled trial. Psychooncology 2007;16:277–86.
   PubMed Web of Science ®Google Scholar
• Coyne JC, Hanisch LJ, Palmer SC. Psychotherapy does not promote survival (Kissane et al., 2007): now what? Psychooncology 2007;16:1050–2.
   PubMed Web of Science ®Google Scholar
• Kissane D. Beyond the psychotherapy and survival debate: the challenge of social disparity, depression and treatment adherence in psychosocial cancer care. Psychooncology 2009;18:1–5.
   PubMed Web of Science ®Google Scholar